Robert W. Baird Cuts Mettler-Toledo International (NYSE:MTD) Price Target to $1,034.00

Mettler-Toledo International (NYSE:MTD - Free Report) had its target price reduced by Robert W. Baird from $1,369.00 to $1,034.00 in a research report sent to investors on Tuesday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical instruments supplier's stock.

Other analysts also recently issued reports about the stock. Wells Fargo & Company reduced their price target on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating for the company in a report on Thursday, April 17th. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research report on Monday, February 10th. Finally, Citigroup raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research report on Monday, April 7th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, Mettler-Toledo International currently has a consensus rating of "Hold" and an average target price of $1,304.25.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD traded down $12.48 during midday trading on Tuesday, hitting $1,062.52. The company's stock had a trading volume of 165,723 shares, compared to its average volume of 143,380. The stock's 50 day simple moving average is $1,160.03 and its 200 day simple moving average is $1,245.22. The stock has a market capitalization of $22.14 billion, a price-to-earnings ratio of 26.22, a PEG ratio of 3.30 and a beta of 1.28. Mettler-Toledo International has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other news, insider Gerry Keller sold 600 shares of the business's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the sale, the insider now owns 6 shares in the company, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares of the company's stock, valued at $964,248.46. This represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. SBI Securities Co. Ltd. acquired a new position in Mettler-Toledo International in the fourth quarter worth $33,000. Edmond DE Rothschild Holding S.A. bought a new position in shares of Mettler-Toledo International in the fourth quarter valued at about $44,000. Blue Trust Inc. lifted its position in Mettler-Toledo International by 70.8% during the 4th quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier's stock worth $50,000 after buying an additional 17 shares in the last quarter. Golden State Wealth Management LLC grew its holdings in Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after acquiring an additional 35 shares during the last quarter. Finally, Whipplewood Advisors LLC acquired a new stake in Mettler-Toledo International in the 4th quarter valued at about $54,000. 95.07% of the stock is owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.